Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous lymphocytosis in cats is a slowly progressing, relatively benign disease affecting older cats, often causing skin lesions and systemic signs.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Dogs have a skin condition like human pseudopelade, causing hair loss that doesn't improve with treatment.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

The conclusion is that it's important to tell apart alopecia areata from lipedematous alopecia for proper treatment, as alopecia areata can be reversed.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.